DE BERNARDI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 7.790
AS - Asia 5.297
EU - Europa 3.550
SA - Sud America 595
Continente sconosciuto - Info sul continente non disponibili 386
AF - Africa 99
OC - Oceania 21
Totale 17.738
Nazione #
US - Stati Uniti d'America 7.299
SG - Singapore 1.643
VN - Vietnam 1.410
IT - Italia 1.196
CN - Cina 875
HK - Hong Kong 602
RU - Federazione Russa 483
BR - Brasile 454
CA - Canada 400
DE - Germania 385
SE - Svezia 257
IE - Irlanda 244
GB - Regno Unito 191
UA - Ucraina 172
BD - Bangladesh 171
FR - Francia 148
IN - India 137
AT - Austria 91
FI - Finlandia 80
KR - Corea 75
TR - Turchia 61
ES - Italia 54
CH - Svizzera 51
AR - Argentina 48
ID - Indonesia 45
PL - Polonia 45
NL - Olanda 43
IQ - Iraq 42
ZA - Sudafrica 41
JP - Giappone 36
DK - Danimarca 31
MX - Messico 30
SA - Arabia Saudita 29
PH - Filippine 23
UZ - Uzbekistan 22
VE - Venezuela 22
CO - Colombia 19
PK - Pakistan 19
AU - Australia 18
EC - Ecuador 18
JM - Giamaica 15
BE - Belgio 14
CZ - Repubblica Ceca 13
MA - Marocco 12
NP - Nepal 12
AE - Emirati Arabi Uniti 10
CL - Cile 10
JO - Giordania 10
BG - Bulgaria 9
MY - Malesia 9
BO - Bolivia 8
LT - Lituania 8
RO - Romania 8
AZ - Azerbaigian 7
CR - Costa Rica 7
ET - Etiopia 7
KE - Kenya 7
TN - Tunisia 7
TW - Taiwan 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
OM - Oman 6
PA - Panama 6
PY - Paraguay 6
TH - Thailandia 6
EG - Egitto 5
HN - Honduras 5
UY - Uruguay 5
IL - Israele 4
NI - Nicaragua 4
PS - Palestinian Territory 4
PT - Portogallo 4
SI - Slovenia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
EU - Europa 3
IR - Iran 3
KG - Kirghizistan 3
LB - Libano 3
MM - Myanmar 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PE - Perù 3
PR - Porto Rico 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
CY - Cipro 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
RS - Serbia 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
Totale 17.329
Città #
Ann Arbor 946
Singapore 795
Ashburn 657
Hong Kong 580
Woodbridge 505
San Jose 423
Ho Chi Minh City 421
Hanoi 404
Fairfield 384
Milan 353
Houston 344
Chandler 326
Toronto 273
Frankfurt am Main 257
Dublin 237
Wilmington 221
New York 194
Jacksonville 178
Santa Clara 169
Los Angeles 167
Dearborn 152
Dallas 150
Cambridge 147
Council Bluffs 147
Seattle 142
Beijing 140
Chicago 124
Princeton 100
Hefei 98
Rome 84
The Dalles 78
Seoul 68
Nanjing 67
Boardman 64
Vienna 63
Lauterbourg 55
Columbus 54
Moscow 52
São Paulo 50
Da Nang 46
Shanghai 46
Buffalo 43
Munich 43
Lawrence 41
Haiphong 40
Altamura 36
London 34
Orem 34
Lachine 32
San Diego 32
Warsaw 32
Ottawa 31
Fremont 30
Quận Bình Thạnh 30
Guangzhou 28
Brooklyn 27
Jakarta 27
San Francisco 27
Thái Nguyên 27
Denver 26
Hải Dương 25
Tokyo 25
Can Tho 24
Dong Ket 24
Montreal 24
Monza 24
Biên Hòa 23
Phoenix 23
Amsterdam 22
Nanchang 22
Johannesburg 21
Lissone 21
Nuremberg 20
Quận Một 20
Stockholm 20
Atlanta 19
Boston 19
Tashkent 19
Washington 19
Chennai 18
Helsinki 18
Baghdad 17
Turin 17
Changsha 16
Ha Long 16
Zurich 16
Ravenna 15
Vũng Tàu 15
Brussels 14
Dhaka 14
Salt Lake City 14
Tianjin 14
Naples 13
Ninh Bình 13
Poplar 13
Turku 12
Jiaxing 11
Kingston 11
Lang Son 11
Mumbai 11
Totale 11.094
Nome #
Implication of tumor morphology and MRI characteristics on the accuracy of automated versus human segmentation of GBM areas 1.330
PET textural features stability and pattern discrimination power for radiomics analysis: An “ad-hoc” phantoms study 505
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 495
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 491
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 458
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 388
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 363
Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211 349
“Under the hood”: artificial intelligence in personalized radiotherapy 335
Preliminary assessment of semiautomated segmentation tool for GBM neurosurgery: a BraTS-Toolkit approach 333
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 330
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 330
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 329
Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation 304
Metodi di segmentazione avanzata: applicazioni in oncologia 301
Radiomics in PI-RADS 3 Multiparametric MRI for Prostate Cancer Identification: Literature Models Re-Implementation and Proposal of a Clinical–Radiological Model 299
PET quantification: strategies for partial volume correction 292
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 283
Performances of Principal Component Analysis for the extraction of respiratory signal from Time-of-Flight PET coincidences stream 279
Reconstruction of uptake patterns in PET: The influence of regularizing prior 276
Towards the Definition of Radiomic Features and Clinical Indices to Enhance the Diagnosis of Clinically Significant Cancers in PI-RADS 4 and 5 Lesions 271
Radiomics and liver: Where we are and where we are headed? 257
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 257
Motion-Tracking Hardware and Advanced Applications in PET and PET/CT 257
Quantitative performance of iterative algorithms, with and without PSF and TOF, in the conditions of a dynamic cardiac 13N-ammonia study 252
4D ML reconstruction as a tool for volumetric PET-based treatment verification in ion beam radiotherapy 251
Artificial intelligence for precision medicine in autoimmune liver disease 250
A Dedicated Tomographic Image Reconstruction Algorithm for Integration-Mode Detector Configuration in Ion Imaging 248
Resolution recovery in PET during AWOSEM reconstruction: a performance evaluation study 242
Analysis of different detector and electronics defects on F18-FDG images 242
Development of a software platform for evaluating automatic PET segmentation methods 239
Proposal of a 4D ML Reconstruction Strategy for PET-based Treatment Verification in Ion Beam Radiotherapy 232
Geometrical interpretation of TOF PET raw data in commercial PET-CT scanner for SNR optimization 232
Lesion quantification in oncological positron emission tomography: A maximum likelihood partial volume correction strategy 230
Joint Segmentation and Quantification of Oncological Lesions in PET/CT: Preliminary Evaluation on a Zeolite Phantom 230
Evaluation of a 2D UNet-Based Attenuation Correction Methodology for PET/MR Brain Studies 230
The use of zeolites to generate PET phantoms for the validation of quantification strategies in oncology 229
ML segmentation strategies for object interference compensation in FDG-PET lesion quantification 222
Technical Note: A new zeolite PET phantom to test segmentation algorithms on heterogeneous activity distributions featured with ground-truth contours 222
Optimized Bayes variational regularization prior for 3D PET images 219
GMM guided automated level set algorithm for PET image segmentation 218
Model based lesion segmentation in FDG-PET from raw data and clinical images 217
Time of flight increases noise in MLEM PET reconstructions stopped early: Theory, simulations and phantoms 217
Non-invasive imaging biomarkers in chronic liver disease 216
Background based Gaussian mixture model lesion segmentation in PET 211
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: validation on 18F-FDG PET data 209
Optimization of rapid acquisition with relaxation enhancement (RARE) pulse sequence parameters for 19F-MRI studies 206
Towards a standard for the evaluation of PET Auto-Segmentation methods: requirements and implementation 205
First clinical investigation of a 4D maximum likelihood reconstruction for 4D PET-based treatment verification in ion beam therapy 197
A simple contrast matching rule for osem reconstructed pet images with different time of flight resolution 196
Clinical investigations of a 4D ML reconstruction strategy for PET-based treatment verification in ion beam therapy 194
Tuning of a 4D ML reconstruction strategy for treatment verification in ion beam radiotherapy 189
Evaluation of frequency-distance relation validity for FORE optimization in 3D PET 184
Iterative joint segmentation and quantification of oncological lesions in PET-CT 181
Regularized ML reconstruction for time/dose reduction in 18F-fluoride PET/CT studies 181
PET-based dosimetry in particle therapy: assessing the feasibility of regional MLEM reconstruction as a quantification tool 176
Protocol assessment for quantitative 19F MRI of low concentrated compounds on a preclinical 7T MRI scanner: preliminary evaluations and results 175
Design of a Benchmark Platform for Evaluating PET-based Contouring Accuracy in Oncology Applications 174
Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke: Rationale and Study Protocol of a Multicenter, Randomized, Proof-of-Concept, Phase 2a/b Trial in Patients Treated With Mechanical Thrombectomy (DOWN-SUITE) 170
PET-CT scanner characterization for PET raw data use in biomedical research 169
Assessment of zeolites for lesion simulation in PET-CT 162
Regional MLEM reconstruction strategy for PET-based treatment verification in ion beam radiotherapy 162
High Field 19F MRI: optimization of Rapid Acquisition with Relaxation Enhancement (RARE) sequences to improve the sensitivity on a preclinical 7T MRI scanner 155
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 136
Identification of Alzheimer’s disease with 18F-FDG-PET and MRI pCASL in MCI and SCD subjects: the CAPE study 130
Radiomics-Based Prognostication in Primary Sclerosing Cholangitis: A Proof-of-Concept Study 83
Radiomic analysis of contrast-enhanced CT for the prediction of microvascular invasion in hepatocellular carcinoma: literature analysis and practical challenges 81
Implementation and 3D extension of dose reconstruction strategies from prompt-gamma emissions in proton therapy 62
Totale 17.738
Categoria #
all - tutte 53.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022606 0 75 82 30 29 36 38 70 25 47 65 109
2022/20231.234 119 319 132 114 96 184 18 74 89 29 31 29
2023/20241.031 45 54 30 71 119 203 157 27 104 36 28 157
2024/20253.660 114 265 134 118 178 110 204 108 214 366 385 1.464
2025/20266.495 525 453 457 593 670 305 890 285 516 609 513 679
2026/2027518 305 213 0 0 0 0 0 0 0 0 0 0
Totale 17.738